Literature DB >> 28546918

B cell receptor signaling pathway involved in benign lymphoepithelial lesions of the lacrimal gland.

Xiao-Na Wang1, Xin Ge1, Jing Li1, Xiao Liu1, Jian-Min Ma1.   

Abstract

AIM: To detect the expression of B cell receptor signaling pathway (BCRSP) in lacrimal gland benign lymphoepithelial lesions (LGBLEL).
METHODS: Gene microarray was used to compare whole-genome expression in lacrimal gland tissues from LGBLEL patients to tissues from orbital cavernous hemangioma (control tissues). Expression of BCRSP was confirmed by polymerase chain reaction (PCR) and immunohistochemistry.
RESULTS: The expression of 22 genes of the BCRSP increased significantly in LGBLEL patients. PCR analysis showed that CD22, CR2, and BTK were all highly expressed in LGBLEL tissues. Immunohistochemical analysis showed that CR2 protein was present in LGBLEL, but CD22 and BTK proteins were negative. CR2, CD22, and BTK were not observed in the orbital cavernous hemangiomas with either PCR or immunohistochemistry.
CONCLUSION: BCRSP might be involved in the pathogenesis of LGBLEL.

Entities:  

Keywords:  B cell receptor signaling pathway; benign lymphoepithelial lesion; lacrimal gland; pathogenesis

Year:  2017        PMID: 28546918      PMCID: PMC5437449          DOI: 10.18240/ijo.2017.05.01

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  16 in total

1.  Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases.

Authors:  Motohisa Yamamoto; Tetsuya Tabeya; Yasuyoshi Naishiro; Hidetaka Yajima; Keisuke Ishigami; Yui Shimizu; Mikiko Obara; Chisako Suzuki; Kentaro Yamashita; Hiroyuki Yamamoto; Toshiaki Hayashi; Shigeru Sasaki; Toshiaki Sugaya; Tadao Ishida; Ken-Ichi Takano; Tetsuo Himi; Yasuo Suzuki; Norihiro Nishimoto; Saho Honda; Hiroki Takahashi; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Mod Rheumatol       Date:  2011-09-28       Impact factor: 3.023

2.  Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling.

Authors:  Francesca Gasparrini; Christoph Feest; Andreas Bruckbauer; Pieta K Mattila; Jennifer Müller; Lars Nitschke; Dennis Bray; Facundo D Batista
Journal:  EMBO J       Date:  2015-12-15       Impact factor: 11.598

3.  Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation.

Authors:  Sheau-Pey Wang; Shigeru Iwata; Shingo Nakayamada; Hiroaki Niiro; Siamak Jabbarzadeh-Tabrizi; Masahiro Kondo; Satoshi Kubo; Maiko Yoshikawa; Yoshiya Tanaka
Journal:  Rheumatology (Oxford)       Date:  2015-02-26       Impact factor: 7.580

4.  Clinical and pathological differences between Mikulicz's disease and Sjögren's syndrome.

Authors:  M Yamamoto; S Harada; M Ohara; C Suzuki; Y Naishiro; H Yamamoto; H Takahashi; K Imai
Journal:  Rheumatology (Oxford)       Date:  2004-10-27       Impact factor: 7.580

5.  [THE COMBINATION OF EXPRESSION OF MARKERS CR1 AND CR2 (CD35/CD21) IN DIAGNOSTIC OF B-CELL LYMPHOPROLIFERATIVE DISEASES].

Authors:  O N Chibisova; D V Burtsev; K M Galstian; G I Lugovskaia
Journal:  Klin Lab Diagn       Date:  2015-04

6.  Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease.

Authors:  Takashi Maehara; Masafumi Moriyama; Hitoshi Nakashima; Katsuhisa Miyake; Jun-Nosuke Hayashida; Akihiko Tanaka; Shouichi Shinozaki; Yoshiaki Kubo; Seiji Nakamura
Journal:  Ann Rheum Dis       Date:  2012-06-29       Impact factor: 19.103

7.  Prevalence of BTK mutations in male Algerian patterns with agammaglobulinemia and severe B cell lymphopenia.

Authors:  Soraya Boushaki; Azzedine Tahiat; Yanis Meddour; Koon Wing Chan; Samia Chaib; Nafissa Benhalla; Leila Smati; Abdellatif Bensenouci; Yu-Lung Lau; Frédérique Magdinier; Réda Djidjik
Journal:  Clin Immunol       Date:  2015-09-24       Impact factor: 3.969

8.  Association of TCR-signaling pathway with the development of lacrimal gland benign lymphoepithelial lesions.

Authors:  Jian-Min Ma; Yi-Xin Cui; Xin Ge; Jing Li; Jin-Ru Li; Xiao-Na Wang
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

9.  Serum IgG4 concentrations and IgG4-related sclerosing disease.

Authors:  Taku Tabata; Terumi Kamisawa; Kensuke Takuma; Hajime Anjiki; Naoto Egawa; Masanao Kurata; Gorou Honda; Kouji Tsuruta; Keigo Setoguchi; Taminori Obayashi; Tsuneo Sasaki
Journal:  Clin Chim Acta       Date:  2009-07-04       Impact factor: 3.786

Review 10.  CD22 and autoimmune disease.

Authors:  Thomas Dörner; Anthony Shock; Kenneth G C Smith
Journal:  Int Rev Immunol       Date:  2012-10       Impact factor: 5.311

View more
  3 in total

1.  Inhibitory effect of CUL1 on atherosclerosis through the p53 pathway.

Authors:  Xi Zhang; Youwei Lu; Wei Jiang; Qianhong Yang
Journal:  Ann Transl Med       Date:  2022-09

2.  The FcεRI signaling pathway is involved in the pathogenesis of lacrimal gland benign lymphoepithelial lesions as shown by transcriptomic analysis.

Authors:  Jing Li; Rui Liu; Mei Sun; Jinjin Wang; Nan Wang; Xuan Zhang; Xin Ge; Jianmin Ma
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

3.  Macrophage migration inhibitory factor contributes to the pathogenesis of benign lymphoepithelial lesion of the lacrimal gland.

Authors:  Yao Mawulikplimi Adzavon; Pengxiang Zhao; Jianmin Ma; Xujuan Zhang; Xin Zhang; Mingzi Zhang; Mengyu Liu; Limin Wang; Danying Chen; Tarekegn Gebreyesus Abisso; Baobei Lv; Lei Wang; Fei Xie; Xuemei Ma
Journal:  Cell Commun Signal       Date:  2018-10-22       Impact factor: 5.712

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.